Detall de la convocatòria

Característiques

Característica
Objectiu de la convocatòria
Projects performed by international consortia that are expected to advance our knowledge of SARS-CoV-2 specifically and the wider coronavirus family in general, with the aim of contributing to an efficient patient management and/or public health preparedness and response to current and future outbreaks of coronavirus infection.
Característiques principals
Considering that this is a newly-identified virus, the scope of this topic remains broad and must address at least one of the following objectives:
  • development of antivirals as well as other types of therapeutics to address a rapid response to the current COVID-19 outbreak;
  • development of therapeutics to address the current and/or future coronavirus outbreaks;
  • development of diagnostics, ensuring rapid evaluation of candidates based on existing technologies;
  • development of fast and reliable tools that go beyond the state of the art for detection of COVID-19 carriers and symptomatic individuals suspected of COVID-19 infection.
    Preventive vaccines are specifically excluded from the scope of the Call.
    • Lloc de presentació
    El personal de l'IMIM i PSMAR que necessiteu més informació adreceu-vos a:
    Servei de Recerca. C/ Doctor Aiguader, 88. 08003 Barcelona. Tel.: 93.316.04.00.
    • Carol Barnwell, [email protected]. Ext.: 1670
    • Marta López, [email protected] Ext.: 1576
    Convocatòria (URL)
    https://www.imi.europa.eu/apply-funding/open-calls/imi2-call-21
    Dotació
    Applicant consortia will be competing for the maximum total financial contribution from IMI2 JU up to EUR 45 000 000

    Arxius

    Arxiu
    IMI2 Call 21 Coronavirus - Call text_final.pdf
    Call21_QandA_FINAL.pdf